{"id":1037664,"date":"2017-04-28T00:46:08","date_gmt":"2017-04-28T04:46:08","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/uncategorized\/ishares-nasdaq-biotechnology-index-ibb-upgraded-to-buy-at-vetr-inc-the-cerbat-gem.php"},"modified":"2024-08-17T16:09:10","modified_gmt":"2024-08-17T20:09:10","slug":"ishares-nasdaq-biotechnology-index-ibb-upgraded-to-buy-at-vetr-inc-the-cerbat-gem","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/ishares-nasdaq-biotechnology-index-ibb-upgraded-to-buy-at-vetr-inc-the-cerbat-gem.php","title":{"rendered":"iShares NASDAQ Biotechnology Index (IBB) Upgraded to Buy at Vetr Inc. – The Cerbat Gem"},"content":{"rendered":"
<\/font><\/td>
\"\"<\/div>
iShares NASDAQ Biotechnology<\/b> Index (IBB) Upgraded to Buy at Vetr Inc.<\/b><\/a>
The Cerbat Gem<\/font><\/b><\/font>
iShares NASDAQ Biotechnology<\/b> Index logo Vetr upgraded shares of iShares NASDAQ Biotechnology<\/b> Index (NASDAQ:IBB) from a hold rating to a buy rating in a research note issued to investors on Wednesday. They currently have $301.57 price target on ...<\/font>
iShares NASDAQ Biotechnology<\/b> Index (IBB) Stake Raised by Mycio Wealth Partners LLC<\/a>Sports Perspectives<\/nobr><\/font><\/font>
iShares NASDAQ Biotechnology<\/b> Index (IBB) Position Lowered by Bartlett & Co. LLC<\/a>BBNS<\/nobr><\/font><\/font>
The Crestwood Advisors Group LLC Acquires 5651 Shares of iShares NASDAQ Biotechnology<\/b> Index (IBB)<\/a>Petro Global News 24<\/nobr><\/font><\/font>
<\/font>
all 6 news articles »<\/b><\/nobr><\/a><\/font><\/div>

<\/p><\/font><\/td><\/tr><\/table>

<\/p>

Follow this link:
iShares NASDAQ Biotechnology Index (IBB) Upgraded to Buy at Vetr Inc. - The Cerbat Gem<\/a><\/p>","protected":false},"excerpt":{"rendered":"

iShares NASDAQ Biotechnology Index (IBB) Upgraded to Buy at Vetr Inc. The Cerbat Gem iShares NASDAQ Biotechnology Index logo Vetr upgraded shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) from a hold rating to a buy rating in a research note issued to investors on Wednesday Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1037664","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1037664"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1037664"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1037664\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1037664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1037664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1037664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}